Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery with or without Neoadjuvant Chemotherapy in Bulky Stage IB Cervical Cancer
NCT00002536Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Dec 1996
- Primary completion
- Aug 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vincristine and cisplatin in Cervical Cancer (CC) (2 arms), sponsored by GOG Foundation. Primary endpoints: Disease Free Survival up to 5 years, Overall Survival up to 5 years and 1 more. Started Dec 1996; status: completed.
02
Drugs
vincristinecisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00002536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002536.